Skip to main content
Year archive

MESOBLAST LTD — 2020 filings

All 152 regulatory filings released by MESOBLAST LTD (MESO) in 2020, sourced directly from the official regulator.

152 Filings
2020 Period
2020 filings (152)
Filing Released Lang
6-K
Foreign Filer Report
2020-12-18 English
Mesoblast Update on COVID-19 ARDS Trial 2 pages 112.2KB
Regulatory Filings
2020-12-17 English
Mesoblast Webcast 2 pages 111.4KB
Regulatory Filings
2020-12-17 English
Pause in Trading 1 page 111.5KB
Regulatory Filings
2020-12-15 English
Trading halt 2 pages 161.2KB
Regulatory Filings
2020-12-15 English
6-K
Foreign Filer Report
2020-12-15 English
Mesoblast Corporate Update Webcast 2 pages 110.1KB
Regulatory Filings
2020-12-14 English
Mesoblast Phase 3 Chronic Heart Failure Results 3 pages 136.7KB
Regulatory Filings
2020-12-14 English
6-K
Foreign Filer Report
2020-12-07 English
Remestemcel-L Reduces Biomarkers for Mortality in SR-aGVHD 2 pages 152.6KB
Regulatory Filings
2020-12-06 English
Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS 3 pages 121.0KB
Regulatory Filings
2020-12-01 English
6-K
Foreign Filer Report
2020-12-01 English
Appendix 2A 15 pages 174.2KB
Regulatory Filings
2020-11-26 English
Mesoblast Chairman Message to 2020 AGM 2 pages 119.3KB
Regulatory Filings
2020-11-23 English
CEO Presentation to 2020 Annual General Meeting 20 pages 1.8MB
Regulatory Filings
2020-11-23 English
Results of Meeting 2 pages 219.9KB
Regulatory Filings
2020-11-23 English
6-K
Foreign Filer Report
2020-11-23 English
6-K
Foreign Filer Report
2020-11-23 English
Mesoblast Corporate Update and Financial Results Webcast 1
Regulatory Filings
2020-11-19 English
First Quarter Financial Results on Form 6-K 96 pages 618.0KB
Regulatory Filings
2020-11-19 English
MSB Q1 Financial Results and Operational Highlights 8 pages 279.6KB
Regulatory Filings
2020-11-19 English
First Quarter Results Presentation 31 pages 2.3MB
Regulatory Filings
2020-11-19 English
Novartis and Mesoblast Remestemcel-L Collaboration 3 pages 153.3KB
Regulatory Filings
2020-11-19 English
6-K
Foreign Filer Report
2020-11-13 English
DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial 3 pages 124.5KB
Regulatory Filings
2020-11-10 English
6-K
Foreign Filer Report
2020-11-02 English
6-K
Foreign Filer Report
2020-10-29 English
COVID-19 ARDS & GVHD Update, Quarterly Report & Appendix 4C 11 pages 200.2KB
Regulatory Filings
2020-10-28 English
Appendix 4G and Corporate Governance Statement 19 pages 210.7KB
Regulatory Filings
2020-10-25 English
Notice of Annual General Meeting and Proxy Form 18 pages 370.1KB
Regulatory Filings
2020-10-25 English
Annual Report to shareholders 237 pages 3.2MB
Regulatory Filings
2020-10-25 English
6-K
Foreign Filer Report
2020-10-23 English
Remestemcel Controlled Study in Crohns & Ulcerative Colitis 3 pages 131.9KB
Regulatory Filings
2020-10-21 English
6-K
Foreign Filer Report
2020-10-15 English
Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment 2 pages 121.7KB
Regulatory Filings
2020-10-12 English
6-K
Foreign Filer Report
2020-10-03 English
Update on BLA for Graft Versus Host Disease 3 pages 101.0KB
Regulatory Filings
2020-10-01 English
Trading Halt 2 pages 160.5KB
Regulatory Filings
2020-09-30 English
6-K
Foreign Filer Report
2020-09-17 English
6-K
Foreign Filer Report
2020-09-16 English
MSB Wins Fierce Biotech Innovation Award for Remestemcel-L 2 pages 114.5KB
Regulatory Filings
2020-09-14 English
Appendix 2A 15 pages 174.9KB
Regulatory Filings
2020-09-09 English
6-K
Foreign Filer Report
2020-09-08 English
Change in substantial holding 4 pages 220.0KB
Regulatory Filings
2020-09-06 English
DSMB Recommends Continuation of Phase 3 COVID-19 Trial 2 pages 116.6KB
Regulatory Filings
2020-09-03 English
6-K
Foreign Filer Report
2020-09-03 English
20-F
Annual Report FY 2020
2020-09-03 English
Change in substantial holding 5 pages 226.9KB
Regulatory Filings
2020-09-01 English
Ethics Approval to Treat COVID-19 Patients in Australia 2 pages 118.7KB
Regulatory Filings
2020-09-01 English
6-K
Foreign Filer Report
2020-08-29 English
Preliminary Final Report including Appendix 4E 238 pages 2.6MB
Regulatory Filings
2020-08-26 English
Annual Financial Results Presentation 37 pages 2.4MB
Regulatory Filings
2020-08-26 English
MSB Annual Financial Results and Operational Progress 10 pages 279.9KB
Regulatory Filings
2020-08-26 English
Mesoblast 2020 Full Year Financial Results Webcast 1
Regulatory Filings
2020-08-25 English
6-K
Foreign Filer Report
2020-08-25 English
Change in substantial holding 4 pages 237.6KB
Regulatory Filings
2020-08-23 English
Change in substantial holding 5 pages 219.3KB
Regulatory Filings
2020-08-20 English
Appendix 2A and Appendix 3G 27 pages 259.6KB
Regulatory Filings
2020-08-19 English
6-K
Foreign Filer Report
2020-08-15 English
ODAC Votes in Favor of Remestemcel-L for GvHD 3 pages 124.4KB
Regulatory Filings
2020-08-13 English
Trading Halt 2 pages 161.3KB
Regulatory Filings
2020-08-12 English
6-K
Foreign Filer Report
2020-08-12 English
Change in substantial holding - Amendment 4 pages 238.4KB
Regulatory Filings
2020-08-11 English
Change in substantial holding - Amendment 5 pages 248.3KB
Regulatory Filings
2020-08-11 English
Update on Scheduled FDA Advisory Committee Meeting 2 pages 115.4KB
Regulatory Filings
2020-08-10 English
6-K
Foreign Filer Report
2020-08-10 English
Change in substantial holding 4 pages 205.4KB
Regulatory Filings
2020-08-09 English
Change in substantial holding 5 pages 101.1KB
Regulatory Filings
2020-08-06 English
Proposed issue of Securities - MSB 5 pages 27.7KB
Regulatory Filings
2020-08-05 English
Appendix 2A 15 pages 171.3KB
Regulatory Filings
2020-08-05 English
6-K
Foreign Filer Report
2020-08-01 English
COVID-19/GVHD Update, Quarterly Report and Appendix 4C 9 pages 182.4KB
Regulatory Filings
2020-07-29 English
6-K
Foreign Filer Report
2020-07-27 English
REGISTRATION STATEMENT
Registration Form
2020-07-27 English
Mesoblast Expands Executive Leadership Team 2 pages 137.2KB
Regulatory Filings
2020-07-23 English
FDA Advisory Committee Sets Review Date for Remestemcel-L 2 pages 114.9KB
Regulatory Filings
2020-07-20 English
6-K
Foreign Filer Report
2020-07-10 English
6-K
Foreign Filer Report
2020-07-07 English
Appendix 3B, 2A with prospectus- Kentgrove Capital 108 pages 862.0KB
Regulatory Filings
2020-07-06 English
EAP for Remestemcel-L in Children with MIS-C due to COVID-19 2 pages 115.0KB
Regulatory Filings
2020-07-05 English
6-K
Foreign Filer Report
2020-07-02 English
Appendix 2A 15 pages 167.1KB
Regulatory Filings
2020-06-29 English
6-K
Foreign Filer Report
2020-06-26 English
Appendix 3G with 3Ys 22 pages 278.9KB
Regulatory Filings
2020-06-23 English
6-K
Foreign Filer Report
2020-06-18 English
Appendix 2A 15 pages 174.9KB
Regulatory Filings
2020-06-15 English
6-K
Foreign Filer Report
2020-06-03 English
Remestemcel-L Improves Outcomes in Inflammatory Lung Disease 3 pages 119.1KB
Regulatory Filings
2020-05-31 English
Appendix 2A 14 pages 168.0KB
Regulatory Filings
2020-05-31 English
6-K
Foreign Filer Report
2020-05-29 English
6-K
Foreign Filer Report
2020-05-29 English
Third Quarter Financial Results on Form 6-K 105 pages 629.2KB
Regulatory Filings
2020-05-27 English
Third Quarter Results Presentation 32 pages 1.8MB
Regulatory Filings
2020-05-27 English
MSB Reports Q3 Financial Results and Operational Highlights 11 pages 288.6KB
Regulatory Filings
2020-05-27 English
6-K
Foreign Filer Report
2020-05-27 English
Change in substantial holding 6 pages 256.7KB
Regulatory Filings
2020-05-26 English
Regulatory Filings 2020
Regulatory Filings
2020-05-26 English
3 Articles on RYONCIL GvHD Trial Results Published in BBMT 4 pages 130.6KB
Regulatory Filings
2020-05-24 English
6-K
Foreign Filer Report
2020-05-19 English
Change in substantial holding 6 pages 101.7KB
Regulatory Filings
2020-05-18 English
Cleansing Notice 1 page 78.8KB
Regulatory Filings
2020-05-17 English
MESO-2020-05-13-6-K
Foreign Filer Report
2020-05-15 English
Appendix 2As 28 pages 287.7KB
Regulatory Filings
2020-05-14 English
MSB Completes Financing For Covid-19 ARDS Manufacturing 2 pages 150.1KB
Regulatory Filings
2020-05-12 English
Proposed issue of Securities - MSB 6 pages 30.8KB
Regulatory Filings
2020-05-12 English
Trading Halt 2 pages 177.6KB
Regulatory Filings
2020-05-10 English
6-K
Foreign Filer Report
2020-05-07 English
First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS 2 pages 134.2KB
Regulatory Filings
2020-05-05 English
6-K
Foreign Filer Report
2020-05-04 English
Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment 2 pages 147.0KB
Regulatory Filings
2020-04-29 English
Appendix 4C - quarterly 10 pages 201.1KB
Regulatory Filings
2020-04-28 English
6-K
Foreign Filer Report
2020-04-24 English
83% Survival in COVID-19 ARDS Patients with Remestemcel-L 3 pages 149.3KB
Regulatory Filings
2020-04-23 English
6-K
Foreign Filer Report
2020-04-20 English
Inflammatory Lung Disease Outcomes For Presentation at ISCT 2 pages 121.0KB
Regulatory Filings
2020-04-16 English
6-K
Foreign Filer Report
2020-04-09 English
US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial 2 pages 101.3KB
Regulatory Filings
2020-04-08 English
6-K
Foreign Filer Report
2020-04-07 English
FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients 2 pages 95.4KB
Regulatory Filings
2020-04-05 English
6-K
Foreign Filer Report
2020-04-02 English
FDA Accepts BLA for RYONCIL and Agrees to Priority Review 2 pages 97.6KB
Regulatory Filings
2020-03-31 English
Ischemic End Stage HF Outcomes at Virtual ACC Annual Meeting 2 pages 100.4KB
Regulatory Filings
2020-03-29 English
6-K
Foreign Filer Report
2020-03-24 English
6-K
Foreign Filer Report
2020-03-20 English
Change of Director's Interest Notice 2 pages 78.0KB
Regulatory Filings
2020-03-19 English
Appendix 2A 14 pages 153.8KB
Regulatory Filings
2020-03-16 English
6-K
Foreign Filer Report
2020-03-11 English
Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease 3 pages 105.9KB
Regulatory Filings
2020-03-09 English
6-K
Foreign Filer Report
2020-02-28 English
Half Year Report and Accounts (including Appendix 4D) 108 pages 804.3KB
Regulatory Filings
2020-02-26 English
Half Year Financial Results Presentation 26 pages 1.5MB
Regulatory Filings
2020-02-26 English
Mesoblast Provides Half Year Results and Corporate Update 9 pages 229.4KB
Regulatory Filings
2020-02-26 English
6-K
Foreign Filer Report
2020-02-26 English
Mesoblast Half Year FY 2020 Financial Results Analyst Call 1
Regulatory Filings
2020-02-24 English
Ryoncil Results in Children with Acute GvHD Presented at TCT 3 pages 156.0KB
Regulatory Filings
2020-02-23 English
Appendix 3G 12 pages 137.5KB
Regulatory Filings
2020-02-20 English
Positive Outcomes Using Remestemcel-L in Chronic GVHD 2 pages 100.4KB
Regulatory Filings
2020-02-19 English
6-K
Foreign Filer Report
2020-02-14 English
SC 13G/A
Major Shareholding Notification
2020-02-14 English
Appendix 2A 15 pages 174.1KB
Regulatory Filings
2020-02-06 English
6-K
Foreign Filer Report
2020-02-05 English
6-K
Foreign Filer Report
2020-02-04 English
Mesoblast Submits Completed BLA for Ryoncil to US FDA 2 pages 122.7KB
Regulatory Filings
2020-02-02 English
MESOBLAST LIMITED
Major Shareholding Notification
2020-01-30 English
Appendix 4C - quarterly 9 pages 227.4KB
Regulatory Filings
2020-01-28 English
Appendix 2A 14 pages 154.4KB
Regulatory Filings
2020-01-23 English
6-K
Foreign Filer Report
2020-01-22 English
MSB Presents Commercial Plans at 2020 Biotech Showcase 2 pages 151.9KB
Regulatory Filings
2020-01-14 English
Biotech Showcase Presentation 37 pages 2.2MB
Regulatory Filings
2020-01-14 English
6-K
Foreign Filer Report
2020-01-14 English
MSB Files GvHD Clinical Efficacy and Safety Data with US FDA 2 pages 135.5KB
Regulatory Filings
2020-01-01 English
Appendix 2A 14 pages 149.8KB
Regulatory Filings
2020-01-01 English